Innovative treatment model for malignant rhabdoid tumor
- Xinrong Lin,
- jian li,
- Qiyang Shen,
- Lulu He,
- Jianfeng Zhou,
- Tao Li,
- Li Zhou
Xinrong Lin
Children's Hospital of Nanjing Medical University
Author Profilejian li
Children's Hospital of Nanjing Medical University
Author ProfileQiyang Shen
Children's Hospital of Nanjing Medical University
Author ProfileLulu He
Children's Hospital of Nanjing Medical University
Author ProfileJianfeng Zhou
Children's Hospital of Nanjing Medical University
Author ProfileLi Zhou
Children's Hospital of Nanjing Medical University
Corresponding Author:zhoulinjey@163.com
Author ProfileAbstract
MRT is a highly malignant tumor that commonly occurs in children.
Despite the current multidisciplinary treatment approach combining
surgery, chemotherapy, and radiotherapy, the 3-year survival rate for
affected children remains significantly low. This article presents three
cases where a novel chemotherapy regimen and maintenance therapy were
employed in conjunction with surgical and radiation treatments,
resulting in favorable therapeutic outcomes. These findings demonstrate
the feasibility and potential of the innovative personalized treatment
approach utilized. Personalized treatment involves tailoring therapeutic
strategies to the specific characteristics and biological behavior of
individual patients. This approach holds promise in improving outcomes
for children with MRT. Further research and clinical application will
contribute to advancing the use of personalized treatment in the
management of MRT.